Altered Expression of CYSLTR1 is Associated With Adverse Clinical Outcome in Triple Negative Breast Tumors: An <i>In Silico</i> Approach
-
Published:2023-04-01
Issue:2
Volume:19
Page:148-158
-
ISSN:2587-0831
-
Container-title:European Journal of Breast Health
-
language:
-
Short-container-title:EJBH
Author:
Céspedes Andrés GalindoORCID, Conceição Mércia Patrícia FerreiraORCID, de Bastos Daniel RodriguesORCID, de Grazia Gabriela ÁvilaORCID, Leite Jean Michel Rocha SampaioORCID, do Nascimento Renan GomesORCID, Ferreira Matthew ThomasORCID, Lopez Rossana MendozaORCID
Publisher
Galenos Yayinevi
Subject
Ocean Engineering
Reference40 articles.
1. 1. Turashvili G, Brogi E. Tumor heterogeneity in breast cancer. Front Med (Lausanne) 2017; 4: 227. (PMID: 29276709) [Crossref] 2. 2. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006; 7: 96. (PMID: 16643655) [Crossref] 3. 3. Sorlie T et al, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-10874. (PMID: 11553815) [Crossref] 4. 4. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752. (PMID: 10963602) [Crossref] 5. 5. Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Cervera N, Tarpin C, et al. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res 2005; 65: 2170-2178. (PMID: 15781628) [Crossref]
|
|